Cornercap Investment Counsel Inc. cut its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 54.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,173 shares of the health services provider's stock after selling 7,316 shares during the period. Cornercap Investment Counsel Inc.'s holdings in Maximus were worth $575,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. V Square Quantitative Management LLC bought a new stake in Maximus during the 3rd quarter valued at approximately $25,000. GAMMA Investing LLC grew its stake in Maximus by 224.5% in the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider's stock worth $29,000 after purchasing an additional 238 shares during the period. Blue Trust Inc. grew its stake in Maximus by 201.5% in the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider's stock worth $33,000 after purchasing an additional 262 shares during the period. Archer Investment Corp raised its holdings in Maximus by 8,788.9% in the second quarter. Archer Investment Corp now owns 800 shares of the health services provider's stock worth $69,000 after purchasing an additional 791 shares in the last quarter. Finally, Ariadne Wealth Management LP purchased a new position in Maximus during the second quarter valued at $90,000. Institutional investors own 97.21% of the company's stock.
Insider Buying and Selling at Maximus
In related news, insider Michelle F. Link sold 1,363 shares of the firm's stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the sale, the insider now owns 6,567 shares of the company's stock, valued at $607,841.52. This trade represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.40% of the company's stock.
Maximus Stock Down 2.0 %
Shares of NYSE:MMS traded down $1.58 during midday trading on Friday, reaching $79.18. The company's stock had a trading volume of 1,131,939 shares, compared to its average volume of 366,490. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.61. The firm has a 50 day moving average of $89.02 and a 200-day moving average of $88.17. The firm has a market capitalization of $4.76 billion, a P/E ratio of 16.60 and a beta of 0.77. Maximus, Inc. has a 12-month low of $76.42 and a 12-month high of $93.97.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, November 30th. Shareholders of record on Friday, November 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date is Friday, November 15th. Maximus's dividend payout ratio (DPR) is presently 25.16%.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.